I don't think the whisky in barrel is worth any where near what...

First 49 Last

Share
Profile

Follow
Balthazar1

796 Posts.

57

08/07/22

15:03

Post #: 62444509
Share

Originally posted by All4Info: ↑

An additional placeholder comment between now and the quarterly (usually released last week of July). And possible other news..

1. Last year LRK released an announcement "Investor Presentation - July 2021" on 6th of July updating whisky under maturation / valuation.

Under continuous disclosure rules the company is required to release information when it is available that a reasonable person would expect is material to the SP.

Now the company has provided previous guidance that NSR is expected to increase 15 - 25% and maturing whisky of 2m litres... If there is no such announcement to confirm this, then it can be reasonably assumed that the EOFY valuation needs to within 5% of that guided valuation for the company to NOT provide an update this week.

So the forecast range is $496m - 540m... Noting Q3 2022 was $422m (1.95m litres at $216) and 2021 EOFY was $236m (1.09m litres at $216 NSR). So we should expect to see in the coming days, or by end of the month a release to the tune of 111% ($260m) increase in whisky under maturation..

2. In Q3 2022 full year guidance of $20 - $24m was reaffirmed (indicating sales forecast of $6.5 - $10.5m in Q4).

If there is an expectation that this is going to be missed, again by 5% or more, and a reasonable person would expect this to impact the SP then an earnings update should be released (if they didnt provide guidance then this would be expected... but they did provide guidance). So if no update on earning, which id probably expect by the end of this week, then we are looking at a base of $19m sales for the year, and 5.5m for the quarter (a $2m increase on the march quarter). 2021 Q4 sales were just shy of $4m. So looking for circa 40% growth on PCP as a base case (assuming no guidance before hand)

Both of the above achieving implied guidance (whisky value) and reaffirmed guidance (sales) is very good news for the SP; IMO.

3. I expect to see some further detail on progress on exporting (i.e. sales to GNT Fine Wines).

One caveat to to the sales forecast and actual results is the timing of the GNT Fine Wines second order (noted in the march Qtly as being expected in June).. If this was missed, then there is higher risk that Q4 sales have been missed....

Just my thoughts, keen to hear any others views.

Cheers.

Expand

I don't think the whisky in barrel is worth any where near what they claim.
Its certainly not worth more than production cost until it is sold in volume at the assumed high value.

LRK Price at posting: $2.70 Sentiment: Sell Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

CC9

Chariot Corp unveils plans for Black Mountain "pilot mine" in Wyoming, US; shares jump +20%

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

FFM

Firefly positioned for copper growth in Canada ahead of resource update

There are more pages in this discussion • 11 more messages in this thread...

First 49 Last

Add LRK (ASX) to my watchlist

(20min delay)
Last $1.00		Change 0.000(0.00%)		Mkt cap ! $105.1M

Open	High	Low	Value	Volume
0.0¢	0.0¢	0.0¢	$0	0

Buyers (Bids)

No.	Vol.	Price($)
2	6119	97.5¢

Sellers (Offers)

Price($)	Vol.	No.
$1.00	1000	1

View Market Depth

No.	Vol.	Price($)
2	6119	0.975
1	1020	0.970
2	3183	0.960
3	22011	0.950
1	3000	0.850

Price($)	Vol.	No.
1.000	1000	1
1.010	10000	1
1.030	971	1
1.100	2512	1
1.250	8752	3

Last trade - 12.59pm 03/10/2024 (20 minute delay)

LRK (ASX) Chart

Day chart unavailable

I don't think the whisky in barrel is worth any where near what...

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Chariot Corp unveils plans for Black Mountain "pilot mine" in Wyoming, US; shares jump +20%

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Firefly positioned for copper growth in Canada ahead of resource update

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

I don't think the whisky in barrel is worth any where near what...

Top Stories

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Chariot Corp unveils plans for Black Mountain "pilot mine" in Wyoming, US; shares jump +20%

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Firefly positioned for copper growth in Canada ahead of resource update

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News